Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. The new, compounded offering ...
The study found that GLP-1-based drugs are effective for weight loss in ... claims database as initiating either denosumab or oral bisphosphonates for osteoporosis. Since fracture morbidity ...
The company said this drug could be used as a monotherapy or in combination with an oral GLP-1 agonist. The third program is a subcutaneously injected amylin agonist designed to be long-acting.
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...
“These drugs are efficacious ... “The emergence of oral formulations and combination therapies may also enhance patient adherence and expand treatment options, highlighting the need for continued ...
Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this time following ... with insulin injections rather than oral medication, according to new research.
In addition, due to increased demand, many GLP-1 agonists are listed on the FDA's Drug Shortages list. People also must consider their comfort level regarding injections, which is the form of ...
Compounders also may prepare compounded versions of a drug on FDA’s drug shortages list if the ... offers access to GLP-1 injections in addition to weight management oral medication kits ...
To foray into the lucrative obesity market, Merck MRK announced that it is in-licensing global rights to an investigational oral ... The GLP-1 segment is a very important class of drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback